SCHEMBL8625938

SCHEMBL8625938

COOC(=O)C(OC)c1ccccc1C1CCOCC1

nearest known ligand 0.35

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 2/20 0.35
GLS O94925 1/20 0.35
CYP3A4 P08684 1/20 0.33
ADRA2A P08913 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
GBA1 P04062 1/20 0.33
HCRTR2 O43614 2/20 0.33
KAT2B Q92831 1/20 0.33
BAZ2B Q9UIF8 1/20 0.33
KMT2A Q03164 2/20 0.32
TSHR P16473 1/20 0.32
SLC6A3 Q01959 2/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21784764 0.80 TSHR (0.39) PDE10ACYP3A4KAT2BBAZ2BTSHR
SCHEMBL21780570 0.77 SLC6A3 (0.39) PDE10ACYP3A4KAT2BBAZ2BTSHR
SCHEMBL10334674 0.77 GBA1 (0.41) ADRA2AADRA2BADRA2CGBA1HCRTR2
SCHEMBL10335608 0.75 ADRA2A (0.38) ADRA2AADRA2BADRA2CGBA1HCRTR2
SCHEMBL16234728 0.74 ADRA2A (0.38) PDE10AADRA2AADRA2BADRA2CGBA1
SCHEMBL22156257 0.74 ADRA2A (0.39) PDE10ACYP3A4ADRA2AADRA2BADRA2C
SCHEMBL22152594 0.69 ADRA2A (0.36) PDE10AADRA2AADRA2BADRA2CKAT2B
SCHEMBL18721784 0.68 KAT2B (0.40) PDE10ACYP3A4KAT2BBAZ2BTSHR
SCHEMBL18197670 0.65 KAT2B (0.43) PDE10AKAT2BBAZ2B
SCHEMBL28068627 0.65 TSHR (0.39) ADRA2AADRA2BADRA2CGBA1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0828736-A1 SUBSTITUTED SULFONYLPHENYLHETEROCYCLES AS CYCLOOXYGENASE-2 AND 5-LIPOXYGENASE INHIBITORS G.D. SEARLE & CO. (US) 1998-03-18 EP disclosed
WO-1996038442-A1 SUBSTITUTED SULFONYLPHENYLHETEROCYCLES AS CYCLOOXYGENASE-2 AND 5-LIPOXYGENASE INHIBITORS G.D. SEARLE & CO. (US) 1996-12-05 WO disclosed